HDAC and HDACi: pathogenetic and mechanistic insights (original) (raw)
- Research Highlight
- Published: 18 October 2011
Rheumatoid arthritis
Nature Reviews Rheumatology volume 7, page 682 (2011)Cite this article
- 872 Accesses
- 13 Citations
- Metrics details
Subjects
Epigentic mechanisms help to regulate proinflammatory cytokine production and, thus, might be important in the pathogenesis of rheumatoid arthritis (RA). Histone deacetylases (HDACs) remove acetyl groups from lysine residues of histones, resulting in chromatin condensation and repression of transcription; as key players in the control of chromatin dynamics they could be a novel therapeutic target in RA. Despite extensive research, many questions remain unanswered regarding the role of HDAC in RA pathogenesis, whether HDAC inhibitors (HDACi) could really work in this disease, and the mechanisms of action of these agents. Two new papers add to our knowledge of this interesting area of research.
The authors also tested the effects of two HDACi on cytokine production: trichostatin A (TSA), a nonselective HDACi, and MI192, a new HDAC3-selective inhibitor developed by Ron Grigg. MI192 showed a dose-dependent inhibition of IL-6 in RA PBMC but not in healthy PBMC, whereas TSA was a potent inhibitor of IL-6 production by both cell types.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
ORIGINAL RESEARCH PAPERS
- Gillepsie, J. et al. Histone deacetylases are dysregulated in rheumatoid arthritis and a novel HDAC3-selective inhibitor reduces IL-6 production by PBMC of RA patients. Arthritis Rheum. doi:10.1002/art.33382
Article CAS Google Scholar - Grabiec, A. M. et al. Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. Ann. Rheum. Dis. doi:10.1136/ard.2011.154211
Article Google Scholar
Rights and permissions
About this article
Cite this article
Buckland, J. HDAC and HDACi: pathogenetic and mechanistic insights.Nat Rev Rheumatol 7, 682 (2011). https://doi.org/10.1038/nrrheum.2011.162
- Published: 18 October 2011
- Issue date: December 2011
- DOI: https://doi.org/10.1038/nrrheum.2011.162